EGFR and salivary gland carcinoma: A case report indicated that the combination of radiotherapy and cetuximab was well-tolerated and showed a complete remission in a patient with recurrent high grade MEC [201], suggesting that, as for SCC, the combination of anti-EGFR and conventional therapies could be more effective than anti-EGFR monotherapy to manage salivary gland carcinomas.